These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36113638)

  • 21. Developmental, learning, and emotional problems. Health of our nation's children, United States, 1988.
    Zill N; Schoenborn CA
    Adv Data; 1990 Nov; (190):1-18. PubMed ID: 10145361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosed Developmental Disabilities in Children Aged 3-17 Years: United States, 2019-2021.
    Zablotsky B; Ng AE; Black LI; Blumberg SJ
    NCHS Data Brief; 2023 Jul; (473):1-8. PubMed ID: 37440277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of developmental and behavioral disorders in a pediatric hospital.
    Petersen MC; Kube DA; Whitaker TM; Graff JC; Palmer FB
    Pediatrics; 2009 Mar; 123(3):e490-5. PubMed ID: 19254983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental and behavioral comorbidities of asthma in children.
    Blackman JA; Gurka MJ
    J Dev Behav Pediatr; 2007 Apr; 28(2):92-9. PubMed ID: 17435459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
    ;
    MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019.
    Adkins SH; Anderson KN; Goodman AB; Twentyman E; Danielson ML; Kimball A; Click ES; Ko JY; Evans ME; Weissman DN; Melstrom P; Kiernan E; Krishnasamy V; Rose DA; Jones CM; King BA; Ellington SR; Pollack LA; Wiltz JL;
    JAMA Pediatr; 2020 Jul; 174(7):e200756. PubMed ID: 32421164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hearing impairment and psychopathological disorders in children and adolescents. Review of the recent literature].
    Bailly D; Dechoulydelenclave MB; Lauwerier L
    Encephale; 2003; 29(4 Pt 1):329-37. PubMed ID: 14615703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with depression and anxiety in children with intellectual disabilities.
    Whitney DG; Shapiro DN; Peterson MD; Warschausky SA
    J Intellect Disabil Res; 2019 May; 63(5):408-417. PubMed ID: 30588708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Health Care, Family, and Community Factors Associated with Mental, Behavioral, and Developmental Disorders Among Children Aged 2-8 Years in Rural and Urban Areas - United States, 2011-2012.
    Robinson LR; Holbrook JR; Bitsko RH; Hartwig SA; Kaminski JW; Ghandour RM; Peacock G; Heggs A; Boyle CA
    MMWR Surveill Summ; 2017 Mar; 66(8):1-11. PubMed ID: 28301449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A national profile of childhood epilepsy and seizure disorder.
    Russ SA; Larson K; Halfon N
    Pediatrics; 2012 Feb; 129(2):256-64. PubMed ID: 22271699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Influencing Low Prevalence of Neurodevelopmental Disabilities Among US Hispanic/Latino Children.
    Garcia S; Hall-Lande J; Nye-Lengerman K
    J Racial Ethn Health Disparities; 2019 Dec; 6(6):1107-1121. PubMed ID: 31292923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of the COVID-19 pandemic on children and young people.
    Magklara K; Kyriakopoulos M
    Psychiatriki; 2023 Dec; 34(4):265-268. PubMed ID: 37982248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Children Aged 3-17 Years With Developmental Disabilities, by Urbanicity: United States, 2015-2018.
    Zablotsky B; Black LI
    Natl Health Stat Report; 2020 Feb; (139):1-7. PubMed ID: 32510313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between screen time and developmental and behavioral problems among children in the United States: evidence from 2018 to 2020 NSCH.
    Qu G; Hu W; Meng J; Wang X; Su W; Liu H; Ma S; Sun C; Huang C; Lowe S; Sun Y
    J Psychiatr Res; 2023 May; 161():140-149. PubMed ID: 36924568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Preeclampsia and Perinatal Complications With Offspring Neurodevelopmental and Psychiatric Disorders.
    Kong L; Chen X; Liang Y; Forsell Y; Gissler M; Lavebratt C
    JAMA Netw Open; 2022 Jan; 5(1):e2145719. PubMed ID: 35089349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study.
    dosReis S; N'Dri L; Ross M; Camelo Castillo W; Reeves G; Butler B
    Acad Pediatr; 2020 Mar; 20(2):241-249. PubMed ID: 31128382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated Prevalence of Children With Diagnosed Developmental Disabilities in the United States, 2014-2016.
    Zablotsky B; Black LI; Blumberg SJ
    NCHS Data Brief; 2017 Nov; (291):1-8. PubMed ID: 29235982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and health impact of developmental disabilities in US children.
    Boyle CA; Decouflé P; Yeargin-Allsopp M
    Pediatrics; 1994 Mar; 93(3):399-403. PubMed ID: 7509480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting optimal development: screening for behavioral and emotional problems.
    Weitzman C; Wegner L; ; ; ; ;
    Pediatrics; 2015 Feb; 135(2):384-95. PubMed ID: 25624375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review.
    Olusanya BO; Smythe T; Ogbo FA; Nair MKC; Scher M; Davis AC
    Front Public Health; 2023; 11():1122009. PubMed ID: 36891340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.